Autopsy report · NCT02506985
XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
Cause of deathNo reason given
Life of this trial
- Ran for about 11 months before it stopped.
- 10 participants enrolled.
- Results were posted on the registry 2 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Susan Smyth
- Sponsor type
- University, hospital or other
- Conditions
- Pulmonary Embolism; Venous Thrombosis
- Interventions
- rivaroxaban; warfarin
- Participants
- 10
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.